Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianning Jiang

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Medicine|March 6, 2026
Suspected doxycycline-induced thrombocytopenia: Two case reports and a review of the literatureFangpeng Ling, Xuemei Chen, Binling Fan, et al.
Anticancer Research|August 30, 2023
Correlation Between Serum ESPL1 and Hepatitis B Virus-related Hepatocellular Carcinoma Histological Grade: A Chinese Single-center Case-control StudyBobin Hu, L U Wei, Hengkai Liang, et al.
International Journal of General Medicine|June 11, 2024
Impact of HBV Integration on Hepatocellular Carcinoma After Long-Term Antiviral TherapyHang Wang, Bobin Hu, Hengkai Liang, et al.
Frontiers in Medicine|November 24, 2025
Assessment of the risk of discontinuation of tenofovir disoproxil fumarate after delivery and the benefit of continued treatment in patients with immune toleranceHuan Liang, Hengkai Liang, Bobin Hu, et al.
Frontiers in Medicine|March 10, 2025
Evaluating the predictive value of clinical models for HBV-related hepatocellular carcinoma: A meta-analysisLong Huang, Luhuai Feng, Yang Lu, et al.
Frontiers in Oncology|April 18, 2025
Evaluation of serum ESPL1 as a biomarker for early diagnosis of HBV-related hepatocellular carcinomaLu-Huai Feng, Lu Wei, Bobin Hu, et al.
Anticancer Research|January 2, 2020
High Rate of Detection of Human ESPL1-HBV S Fusion Gene in Patients With HBV-related Liver Cancer: A Chinese Case-Control StudyBobin Hu, Wen Huang, Rongming Wang, et al.
Therapeutic Advances in Chronic Disease|June 27, 2022
Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scoresYan Huang, Lichang Chen, Rui Huang, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Structural insights into regulation of TRPM7 divalent cation uptake by the small GTPase ARL15Luba Mahbub, Guennadi Kozlov, Pengyu Zong, et al.
Elife|July 14, 2023
Structural insights into regulation of CNNM-TRPM7 divalent cation uptake by the small GTPase ARL15Luba Mahbub, Guennadi Kozlov, Pengyu Zong, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Medicine|March 6, 2026
Suspected doxycycline-induced thrombocytopenia: Two case reports and a review of the literatureFangpeng Ling, Xuemei Chen, Binling Fan, et al.
Anticancer Research|August 30, 2023
Correlation Between Serum ESPL1 and Hepatitis B Virus-related Hepatocellular Carcinoma Histological Grade: A Chinese Single-center Case-control StudyBobin Hu, L U Wei, Hengkai Liang, et al.
International Journal of General Medicine|June 11, 2024
Impact of HBV Integration on Hepatocellular Carcinoma After Long-Term Antiviral TherapyHang Wang, Bobin Hu, Hengkai Liang, et al.
Frontiers in Medicine|November 24, 2025
Assessment of the risk of discontinuation of tenofovir disoproxil fumarate after delivery and the benefit of continued treatment in patients with immune toleranceHuan Liang, Hengkai Liang, Bobin Hu, et al.
Frontiers in Medicine|March 10, 2025
Evaluating the predictive value of clinical models for HBV-related hepatocellular carcinoma: A meta-analysisLong Huang, Luhuai Feng, Yang Lu, et al.
Frontiers in Oncology|April 18, 2025
Evaluation of serum ESPL1 as a biomarker for early diagnosis of HBV-related hepatocellular carcinomaLu-Huai Feng, Lu Wei, Bobin Hu, et al.
Anticancer Research|January 2, 2020
High Rate of Detection of Human ESPL1-HBV S Fusion Gene in Patients With HBV-related Liver Cancer: A Chinese Case-Control StudyBobin Hu, Wen Huang, Rongming Wang, et al.
Therapeutic Advances in Chronic Disease|June 27, 2022
Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scoresYan Huang, Lichang Chen, Rui Huang, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Structural insights into regulation of TRPM7 divalent cation uptake by the small GTPase ARL15Luba Mahbub, Guennadi Kozlov, Pengyu Zong, et al.
Elife|July 14, 2023
Structural insights into regulation of CNNM-TRPM7 divalent cation uptake by the small GTPase ARL15Luba Mahbub, Guennadi Kozlov, Pengyu Zong, et al.
Pageof 4